Consensus Xencor, Inc.

Equities

XNCR

US98401F1057

Market Closed - Nasdaq 04:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
19.23 USD +1.10% Intraday chart for Xencor, Inc. +1.48% -9.42%

Evolution of the average Target Price on Xencor, Inc.

Price target over the last 5 years

History of analyst recommendation changes

6d.gVdX3XRDwJ5nlA7KINQzOrrST4RIr2kJC0FSEMe8n58.0AE5syAgtcoS3n-JVYFESPD_IPY_-AE-M3RmSoaM0f7nJAGJBhu4zCbhNg~fa4a20f04465a85da66336eb7cb90ea1
BTIG Cuts Price Target on Xencor to $38 From $56, Keeps Buy Rating MT
Wedbush Adjusts Xencor's Price Target to $34 From $36, Keeps Outperform Rating MT
RBC Cuts Price Target on Xencor to $32 From $36, Keeps Outperform, Speculative Risk MT
Wedbush Trims Xencor's PT to $36 From $37 After Stopping XmAb104 Development, Opting Out of Cost Sharing With Genentech to Co-develop XmAb306; Maintains Outperform Rating MT
BofA Securities Starts Xencor at Buy With $42 Price Target MT
Berenberg Bank Adjusts Xencor Price Target to $45 From $48, Maintains Buy Rating MT
Wedbush Adjusts Xencor's Price Target to $37 From $39, Keeps Outperform Rating MT
Canaccord Genuity Adjusts Xencor's Price Target to $42 From $48, Keeps Buy Rating MT
Wedbush Lifts Xencor's Price Target to $39 From $35, Keeps Outperform Rating MT
JPMorgan Adjusts Price Target on Xencor to $42 From $37, Maintains Overweight Rating MT
EF Hutton Initiates Coverage on Xencor at Buy With $42 Price Target MT
Cowen Starts Xencor at Outperform MT
RBC Cuts Price Target on Xencor to $36 From $40, Maintains Outperform Rating, Speculative Risk Qualifier MT
Raymond James Upgrades Xencor to Strong Buy from Outperform, Sets $58 Price Target MT
JPMorgan Starts Xencor at Overweight With $37 Price Target MT
Wedbush Lowers Price Target for Xencor to $35 From $48, Maintains Outperform Rating MT
RBC Cuts Price Target on Xencor to $40 From $42, Maintains Outperform Rating, Speculative Risk Qualifier MT
Canaccord Genuity Assumes Xencor at Buy With $50 Price Target MT
Piper Sandler Lowers Xencor's Price Target to $42 From $66, Maintains Overweight Rating MT
Piper Sandler Adjusts Xencor Price Target to $42 From $66, Maintains Overweight Rating MT
Berenberg Bank Adjusts Xencor's Price Target to $48 From $55, Maintains Buy Rating MT
Wedbush Lowers Xencor's Price Target to $48 From $56, Citing Cost of Capital, Cut Programs, Ultomiris Sales Estimates; Outperform Rating Kept MT
HC Wainwright Adjusts Xencor's Price Target to $55 From $61, Reiterates Buy Rating MT
RBC Cuts Price Target on Xencor to $48 From $53, Maintains Outperform-Speculative Risk Rating MT
Wedbush Adjusts Xencor's Price Target to $56 From $54, Keeps Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
19.23 USD
Average target price
36.18 USD
Spread / Average Target
+88.15%
High Price Target
58 USD
Spread / Highest target
+201.61%
Low Price Target
22 USD
Spread / Lowest Target
+14.40%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Xencor, Inc.

BTIG
Wedbush
RBC Capital Markets
BofA Securities
Berenberg Bank
Canaccord Genuity
JPMorgan Chase
EF Hutton
Cowen
Raymond James
Piper Sandler
HC Wainwright
BMO Capital
SMBC Nikko
Guggenheim
SVB Leerink
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
  1. Stock Market
  2. Equities
  3. XNCR Stock
  4. Consensus Xencor, Inc.